About HCG City Cancer Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Helsinn Healthcare SA
2
Ayana Pharma Ltd.,
1
Bayer
1
Hoffmann-La Roche
1
Clinical Trials at HCG City Cancer Centre
During the past decade, HCG City Cancer Centre conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
2011-07-01
2012-11-01
Completed
743
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "HCG City Cancer Centre"
#1 collaborator was "Parexel" with 2 trials as a collaborator and "Lambda Therapeutic Research Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at HCG City Cancer Centre
According to Clinical.Site data, the most researched conditions in "HCG City Cancer Centre" are
"Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Early Breast Cancer" (1 trials), "Non-metastatic Castration-resistant Prostate Cancer" (1 trials) and "Ovarian Cancer Recurrent" (1 trials). Many other conditions were trialed in "HCG City Cancer Centre" in a lesser frequency.
Clinical Trials Intervention Types at HCG City Cancer Centre
Most popular intervention types in "HCG City Cancer Centre" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Doxorubicin Hydrochloride Liposome Injection" (1 trials), "Endocrine Therapy of Physician's Choice" (1 trials) and "Giredestrant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at HCG City Cancer Centre
The vast majority of trials in "HCG City Cancer Centre" are
3 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at HCG City Cancer Centre
Currently, there are NaN active trials in "HCG City Cancer Centre".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in HCG City Cancer Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in HCG City Cancer Centre, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".